A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MDMA

Search Conditions:
Search Keyword : MDMA
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: MDMA
Appearance Frequency: 1911 time(s)
Long forms: 45

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
3,4-methylenedioxymethamphetamine
(1784 times)
Pharmacology
(367 times)
MDA (248 times)
DA (97 times)
MA (81 times)
1986 Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.
methamphetamine, 3,4-methylenedioxymethamphetamine
(55 times)
Chemistry Techniques, Analytical
(11 times)
MDEA (7 times)
MDA (6 times)
BE (3 times)
1996 Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex.
N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane
(18 times)
Biochemistry
(14 times)
DOM (6 times)
8-OH-DPAT (2 times)
1-PP (1 time)
1989 Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
N-methyl-3,4-methylenedioxyamphetamine
(8 times)
Jurisprudence
(2 times)
ATS (2 times)
HPLC (2 times)
MDE (2 times)
1990 Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats.
main metabolites of 3,4-methylenedioxymethamphetamine
(4 times)
Toxicology
(2 times)
HMMA (2 times)
GC (1 time)
GC-MS (1 time)
2008 Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats.
methamphetamine and of ecstasy
(2 times)
Public Health
(1 time)
HIM (1 time)
2005 Crystal methamphetamine and ecstasy differ in relation to unsafe sex among young gay men.
N-methyl-MDA
(2 times)
Chemistry Techniques, Analytical
(1 time)
MDA (2 times)
MTPA (2 times)
GC-MS (1 time)
1987 Synthesis, identification, and acute toxicity of some N-alkyl derivatives of 3,4-methylenedioxyamphetamine.
3,4-methylenedioxymethamphetamine hydrochloride
(1 time)
Environmental Pollution
(1 time)
CA (1 time)
CHL/IU (1 time)
MN (1 time)
2007 Geonotoxicity study of illegal drug MDMA and its nitroso derivative N-MDMA by micronucleus and chromosomal aberration tests using Chinese hamsger lung fibroblast cell line.
4,4'-methylenebis(N,N-dimethylaniline)
(1 time)
Pharmacology
(1 time)
TMB (1 time)
2001 [Formation mechanism of 4,4-methylenebis(N,N-dimethylaniline) by the anodic oxidation of N,N-dimethylaniline].
10  CYP2D6-mediated metabolites of 3,4-methylenedioxymethamfetamine
(1 time)
Toxicology
(1 time)
CYP2D6 (1 time)
2015 CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.
11  impaired decision-making in abstinent Ecstasy
(1 time)
Neurology
(1 time)
CARROT (1 time)
RDMT (1 time)
2006 Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naive controls.
12  main compound of Ecstasy
(1 time)
Behavioral Sciences
(1 time)
AAT (1 time)
MCS (1 time)
SSRI (1 time)
2009 Effects of chronic intracerebroventricular 3,4-methylenedioxy-N-methamphetamine (MDMA) or fluoxetine on the active avoidance test in rats with or without exposure to mild chronic stress.
13  man was admitted to the hospital with an ecstasy
(1 time)
Medicine
(1 time)
--- 2007 [Fatal ecstasy intoxication in a 22-year-old man].
14  Marked decline in 3,4-methylenedioxymethamphetamine
(1 time)
Substance-Related Disorders
(1 time)
--- 2011 Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis.
15  market, sold mainly as amphetamine or ecstasy
(1 time)
Substance-Related Disorders
(1 time)
CI (1 time)
DIMS (1 time)
2015 4-Fluoroamphetamine in the Netherlands: more than a one-night stand.
16  mass-media has presented many articles concerning Ecstasy
(1 time)
Brain
(1 time)
--- 1999 [New synthesis empathogenic agents].
17  MDMA dissolved in PBS
(1 time)
Medicine
(1 time)
i.p (1 time)
2015 Expression of bax and bcl2 Genes in MDMA-induced Hepatotoxicity on Rat Liver Using Quantitative Real-Time PCR Method through Triggering Programmed Cell Death.
18  MDMA provides a power-law relation between the fluctuation function F
(1 time)
Biomedical Engineering
(1 time)
BIS (1 time)
DMA (1 time)
DOA (1 time)
2010 An improved detrended moving-average method for monitoring the depth of anesthesia.
19  MDMA-treated mice
(1 time)
Psychopharmacology
(1 time)
DID (1 time)
2012 Behavioural and neuroinflammatory effects of the combination of binge ethanol and MDMA in mice.
20  measures was high especially when participants were treated with 3.4-methylenedioxy-methamphetamine
(1 time)
Psychopharmacology
(1 time)
--- 2012 Effects of alcohol (BAC 0.5‰) and ecstasy (MDMA 100 mg) on simulated driving performance and traffic safety.
21  mechanisms underlying (+)-3,4-methylenedioxymethamphetamine
(1 time)
Neurology
(1 time)
AADC (1 time)
DA (1 time)
DOPA (1 time)
2006 L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.
22  Memory deficits associated with recreational use of ecstasy
(1 time)
Psychopharmacology
(1 time)
--- 1999 Memory deficits associated with recreational use of "ecstasy" (MDMA).
23  Memory function and serotonin transporter promoter gene polymorphism in ecstasy
(1 time)
Psychopharmacology
(1 time)
--- 2006 Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
24  memory in pure and polyvalent ecstasy
(1 time)
Neurology
(1 time)
--- 2003 Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users.
25  Mental disorders in current and former heavy ecstasy
(1 time)
Substance-Related Disorders
(1 time)
DSM-IV (1 time)
2005 Mental disorders in current and former heavy ecstasy (MDMA) users.
26  methamphetamine, 3,4-methylenedioxymethamphetamine hydrochloride
(1 time)
Jurisprudence
(1 time)
IMS (1 time)
NFLIS (1 time)
OTC (1 time)
2011 Reliability of ion mobility spectrometry for qualitative analysis of complex, multicomponent illicit drug samples.
27  Methodological weaknesses in non-randomized studies of ecstasy
(1 time)
Neurology
(1 time)
--- 2012 Methodological weaknesses in non-randomized studies of ecstasy (MDMA) use: a cautionary note to readers and reviewers.
28  methylenedioxylatedphenethylamines, 3,4-methylenedioxymethamphetamine
(1 time)
Jurisprudence
(1 time)
--- 2008 Thin layer chromatography/fluorescence detection of 3,4-methylenedioxy-methamphetamine and related compounds.
29  mice treated with the 5-HT-releasing agents (+)3,4-methylenedioxy-N-methylamphetamine
(1 time)
Psychopharmacology
(1 time)
PPI (1 time)
WT (1 time)
2000 Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice.
30  microinjection of (+)-3,4-methylenedioxymethamphetamine
(1 time)
Brain
(1 time)
5-HIAA (1 time)
DR (1 time)
MR (1 time)
1992 Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).
31  mitochondrial dysfunction in 3,4-methylenedioxymethamphetamine
(1 time)
Toxicology
(1 time)
--- 2014 MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner.
32  modified detrended moving average analysis
(1 time)
Physics
(1 time)
DFA (1 time)
DMA (1 time)
FA (1 time)
2013 Scaling range of power laws that originate from fluctuation analysis.
33  modified DMA
(1 time)
Biomedical Engineering
(1 time)
BIS (1 time)
DMA (1 time)
DOA (1 time)
2010 An improved detrended moving-average method for monitoring the depth of anesthesia.
34  modulation includes studies administering oxytocin, ecstasy
(1 time)
Pharmacology
(1 time)
--- 2015 Social cognition.
35  monoamine releasing agent (+)-3,4-methylenedioxymethamphetamine
(1 time)
Chemistry Techniques, Analytical
(1 time)
4,4'-DMAR (1 time)
MDMAR (1 time)
SERT (1 time)
2015 Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR).
36  monoamine-depleting effects of the psychostimulant +3,4-methylenedioxymethamphetamine
(1 time)
Drug Therapy
(1 time)
CORT (1 time)
CUS (1 time)
DA (1 time)
2010 Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
37  morphine, diacetylmorphine, methylenedioxyamphetamine
(1 time)
Brain
(1 time)
BBB (1 time)
CNS (1 time)
2009 Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs.
38  morphine, O-6-monoacetylmorphine, cocaine, codeine, methylenedioxymethamphetamine
(1 time)
Chemistry Techniques, Analytical
(1 time)
BEG (1 time)
OF (1 time)
THC (1 time)
2011 UHPLC-ESI-MS/MS method for direct analysis of drugs of abuse in oral fluid for DUID assessment.
39  mucosal oedema induced by ecstasy
(1 time)
Dentistry
(1 time)
--- 2007 Widespread oral and oropharyngeal mucosal oedema induced by ecstasy (MDMA): A case for concern.
40  myocardial morphology after a single ecstasy
(1 time)
Jurisprudence
(1 time)
AA (1 time)
CBN (1 time)
GPx (1 time)
2008 Cardiac oxidative stress determination and myocardial morphology after a single ecstasy (MDMA) administration in a rat model.
41  N-Me-MDA
(1 time)
Chemistry
(1 time)
PMA (1 time)
1982 Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.
42  N-methyl-3,4-methyldioxyphenylisopropylamine
(1 time)
Chemistry Techniques, Analytical
(1 time)
--- 2007 Correlation between the synthetic origin of methamphetamine samples and their 15N and 13C stable isotope ratios.
43  N-methylated derivative, 3,4-methylenedioxymethamphetamine
(1 time)
Pharmacology
(1 time)
5-HIAA (1 time)
5-HT (1 time)
MDA (1 time)
1987 A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives.
44  N-OH-MDMA and 3,4-methylenedioxymethamphetamine
(1 time)
Toxicology
(1 time)
N-OH MDA (1 time)
N-OH-MDMA (1 time)
2011 Urinary excretion profiles of N-hydroxy-3,4-methylenedioxymethamphetamine in rats.
45  P-methoxyamphetamine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and (+/-)3,4-methylenedioxymethamphetamine
(1 time)
Genetics, Medical
(1 time)
DEX (1 time)
MAMP (1 time)
NDM (1 time)
2001 Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates.